ロード中...
Improving and maintaining responses in pediatric B-ALL CAR-T therapy
CAR T therapy has heralded a new era in the treatment of acute lymphoblastic leukemia (ALL) and other hematologic malignancies. In this autologous immunotherapy, patient derived T cells are genetically engineered and then infused back to kill the leukemia cells. The observed response rates in ALL ar...
保存先:
| 出版年: | Cancer J |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130572/ https://ncbi.nlm.nih.gov/pubmed/33750075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000513 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|